-
-
-
-
-
-
-
Black Diamond Therapeutics (BDTX) PT Raised to $7 at Freedom Capital Markets
-
-
-
-
-
-
-
Guggenheim Starts Black Diamond Therapeutics (BDTX) at Buy
-
-
-
-
-
-
-
Black Diamond Therapeutics (BDTX) PT Lowered to $15 at Stifel
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Black Diamond Therapeutics (BDTX)
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Black Diamond Therapeutics (BDTX)
-
-
-
-
-
416,816 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

